Juvederm VOLIFT is a versatile hyaluronic acid-based dermal filler which can be used on various facial areas. It is designed for administration into the deep dermis or lips mucosa. Intended to increase patient comfort during treatment, Lidocaine is included in Juvederm VOLIFT’s formulation.
Approved by the FDA for the correction of moderate to severe facial wrinkles and folds, dermal filler Juvederm VOLIFT is used for facial rejuvenation through facial contouring and augmentation. Created using unique Vycross technology, this newer dermal filler has a combination of low and high molecular weight hyaluronic acid to improve the cross-linking efficiency of the hyaluronic acid chains. Smaller particle size means dermal filler Juvederm VOLIFT’s gel is exceptionally smooth; this advanced technology means the filler delivers very natural-looking outcomes and also contributes to an increased duration of those outcomes.
Dermal filler Juvederm VOLIFT’s applications are multifaceted. It can be used to treat deep Nasolabial Folds, Smoker’s Lines and Marionette Lines. It is also indicated for addressing factors that lead to a less youthful look, such as sagging skin and hollow areas; it does this through volume restoration, contouring of the face, and correction of asymmetries. Treating the under eyes or glabella areas with dermal filler Juvederm VOLIFT is not recommended.
The effects of dermal filler Juvederm VOLIFT can be seen immediately after treatment and can last up to 18 months depending on the individual patient. Regular follow-up sessions are recommended.
Manufactured by Allergan in Europe, dermal filler Juvederm VOLIFT is made with a 17.5 mg/ml concentration of crosslinked sodium hyaluronate that is not of animal origin. Lidocaine is present at a 3mg/ml concentration. Two pre-filled syringes come in each package, with 1 ml of gel in each syringe accompanied by 2 x 30G1/2” needles.